Patents by Inventor Anja Zeller

Anja Zeller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210361754
    Abstract: A treatment of Alzheimer's disease and other disorders involving protein misfolding or aggregation is provided by enhancing or sustaining an antibody response against predominantly directed against pathological protein aggregates or neo-epitopes present on pathogenic forms of said protein or protein complex. Furthermore, therapeutic methods are described, wherein ex vivo stimulated antigen-selected peripheral blood lymphocytes are regrafted into the cognate donor.
    Type: Application
    Filed: December 9, 2020
    Publication date: November 25, 2021
    Inventors: Karsten HENCO, Roger NITSCH, Jan GRIMM, Anja ZELLER, Marcel MAIER
  • Patent number: 10874725
    Abstract: A treatment of Alzheimer's disease and other disorders involving protein misfolding or aggregation is provided by enhancing or sustaining an antibody response against predominantly directed against pathological protein aggregates or neo-epitopes present on pathogenic forms of said protein or protein complex. Furthermore, therapeutic methods are described, wherein ex vivo stimulated antigen-selected peripheral blood lymphocytes are regrafted into the cognate donor.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: December 29, 2020
    Assignee: New York University
    Inventors: Karsten Henco, Roger Nitsch, Jan Grimm, Anja Zeller, Marcel Maier
  • Publication number: 20180110845
    Abstract: A treatment of Alzheimer's disease and other disorders involving protein misfolding or aggregation is provided by enhancing or sustaining an antibody response against predominantly directed against pathological protein aggregates or neo-epitopes present on pathogenic forms of said protein or protein complex. Furthermore, therapeutic methods are described, wherein ex vivo stimulated antigen-selected peripheral blood lymphocytes are regrafted into the cognate donor.
    Type: Application
    Filed: December 18, 2017
    Publication date: April 26, 2018
    Inventors: Karsten HENCO, Roger NITSCH, Jan GRIMM, Anja ZELLER, Marcel MAIER
  • Publication number: 20160354451
    Abstract: A treatment of Alzheimer's disease and other disorders involving protein misfolding or aggregation is provided by enhancing or sustaining an antibody response against predominantly directed against pathological protein aggregates or neo-epitopes present on pathogenic forms of said protein or protein complex. Furthermore, therapeutic methods are described, wherein ex vivo stimulated antigen-selected peripheral blood lymphocytes are regrafted into the cognate donor.
    Type: Application
    Filed: June 9, 2016
    Publication date: December 8, 2016
    Inventors: Karsten Henco, Roger Nitsch, Jan Grimm, Anja Zeller, Marcel Maier
  • Patent number: 9370531
    Abstract: A treatment of Alzheimer's disease and other disorders involving protein misfolding or aggregation is provided by enhancing or sustaining an antibody response against predominantly directed against pathological protein aggregates or neo-epitopes present on pathogenic forms of said protein or protein complex. Furthermore, therapeutic methods are also described, wherein ex vivo stimulated antigen-selected peripheral blood lymphocytes are regrafted into the cognate donor.
    Type: Grant
    Filed: September 1, 2008
    Date of Patent: June 21, 2016
    Assignee: New York University
    Inventors: Karsten Henco, Roger Nitsch, Jan Grimm, Anja Zeller, Marcel Maier
  • Publication number: 20100297108
    Abstract: A novel treatment of Alzheimer's disease and other disorders involving protein misfolding or aggregation is provided by enhancing or sustaining an antibody response against predominantly directed against pathological protein aggregates or neo-epitopes present on pathogenic forms of said protein or protein complex. Furthermore, therapeutic methods are also described, wherein ex vivo stimulated antigen-selected peripheral blood lymphocytes are regrafted into the cognate donor.
    Type: Application
    Filed: September 1, 2008
    Publication date: November 25, 2010
    Inventors: Karsten Henco, Roger Nitsch, Jan Grimm, Anja Zeller, Marcel Maier